Fibrous-cap integrity helps indicate how well a plaque contains its underlying lipid-rich necrotic core. A preserved cap is considered a feature of relative stability, whereas impaired integrity is associated with characteristics linked to thrombosis and cardiovascular events. Characterizing this relationship helps connect microscopic plaque structure with its potential clinical consequences rather than relying on plaque presence alone.
Each assessment domain contributes different information. Structural analysis evaluates features such as fibrous-cap integrity and remodeling, compositional analysis identifies lipid-rich necrotic cores and calcification, and biological assessment addresses inflammation and related activity. Considering these findings together provides a more informative phenotype, supporting distinctions between relatively stable lesions and plaques with clinically concerning characteristics.
These features help define the plaque phenotype beyond its overall size or appearance. A lipid-rich necrotic core describes an important compositional characteristic, calcification provides additional structural information, and inflammation reflects biological activity. Their combined assessment supports interpretation of whether a lesion has features associated with stability, progression, thrombosis, or cardiovascular risk.
The process combines imaging, histological examination, and molecular analysis rather than depending on a single source of evidence. Imaging contributes assessment of plaque structure and remodeling, histology examines tissue composition and organization, and molecular analysis evaluates biological activity. Integrating these findings creates a broader characterization that can be related to clinical significance and patient outcomes.
It is useful when clinicians or investigators need to distinguish relatively stable plaques from lesions with features associated with thrombosis and cardiovascular events. The resulting assessment can support risk assessment and treatment planning, while also helping evaluate therapies. Its value comes from linking plaque characteristics with potential clinical significance rather than treating all atherosclerotic lesions as equivalent.
Plaque phenotype characterization provides a framework for examining how plaque development and progression influence disease. Researchers can relate structural, compositional, and biological findings to diagnostic observations and patient outcomes, creating a connection between vascular biology and clinical medicine. The same framework also supports evaluation of therapies by assessing whether plaque characteristics change in clinically meaningful ways.